PRUDENTIAL FINANCIAL INC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 130 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$10,000
-41.2%
15,2730.0%0.00%
Q4 2021$17,000
-43.3%
15,273
-8.2%
0.00%
Q3 2021$30,000
-28.6%
16,638
+3.7%
0.00%
Q2 2021$42,000
-26.3%
16,048
+1.2%
0.00%
Q1 2021$57,000
+50.0%
15,858
+5.6%
0.00%
Q4 2020$38,0000.0%15,0180.0%0.00%
Q3 2020$38,000
-24.0%
15,018
-1.7%
0.00%
Q2 2020$50,000
+61.3%
15,278
+21.1%
0.00%
Q1 2020$31,000
-53.7%
12,613
-10.6%
0.00%
Q4 2019$67,000
+11.7%
14,1130.0%0.00%
Q3 2019$60,000
-38.1%
14,113
-15.4%
0.00%
Q2 2019$97,000
+79.6%
16,673
+18.8%
0.00%
Q1 2019$54,000
+107.7%
14,0330.0%0.00%
Q4 2018$26,000
-43.5%
14,033
-2.8%
0.00%
Q3 2018$46,000
+7.0%
14,433
+2.4%
0.00%
Q2 2018$43,000
-21.8%
14,0930.0%0.00%
Q1 2018$55,000
-3.5%
14,093
+1.8%
0.00%
Q4 2017$57,000
-37.4%
13,843
-7.1%
0.00%
Q3 2017$91,0000.0%14,893
+1.8%
0.00%
Q2 2017$91,000
+12.3%
14,623
+14.5%
0.00%
Q1 2017$81,000
+19.1%
12,7730.0%0.00%
Q4 2016$68,000
-5.6%
12,7730.0%0.00%
Q3 2016$72,000
+9.1%
12,773
+6.9%
0.00%
Q2 2016$66,000
-19.5%
11,953
+8.1%
0.00%
Q1 2016$82,000
-12.8%
11,053
-2.6%
0.00%
Q4 2015$94,000
-8.7%
11,353
-0.9%
0.00%
Q3 2015$103,000
-24.3%
11,453
+0.9%
0.00%
Q2 2015$136,000
+126.7%
11,353
-23.1%
0.00%
Q2 2014$60,00014,7660.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders